• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACP Journal Club. Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients.

作者信息

Garcia David A

机构信息

University of New Mexico, Albuquerque, New Mexico, USA.

出版信息

Ann Intern Med. 2011 Jul 19;155(2):JC1-7. doi: 10.7326/0003-4819-155-2-201107190-02007.

DOI:10.7326/0003-4819-155-2-201107190-02007
PMID:21768573
Abstract
摘要

相似文献

1
ACP Journal Club. Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients.《美国内科医师学会杂志俱乐部》。在降低重症患者近端深静脉血栓形成方面，达肝素与普通肝素并无差异。
Ann Intern Med. 2011 Jul 19;155(2):JC1-7. doi: 10.7326/0003-4819-155-2-201107190-02007.
2
Dalteparin versus unfractionated heparin in critically ill patients.达肝素与普通肝素在危重症患者中的比较。
N Engl J Med. 2011 Apr 7;364(14):1305-14. doi: 10.1056/NEJMoa1014475. Epub 2011 Mar 22.
3
Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.对265例最初接受普通肝素或达肝素治疗的深静脉血栓形成患者进行长期临床随访：一项回顾性分析。
Thromb Haemost. 1999 Oct;82(4):1222-6.
4
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.达肝素低分子量肝素对重症肾功能严重不全患者深静脉血栓形成的预防：安全性和药效学评估：DIRECT研究
Arch Intern Med. 2008 Sep 8;168(16):1805-12. doi: 10.1001/archinte.168.16.1805.
5
Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.低分子量肝素（达肝素）用于妇科恶性肿瘤女性患者。
Obstet Gynecol. 2005 May;105(5 Pt 1):1006-11. doi: 10.1097/01.AOG.0000153026.61249.c7.
6
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.经皮冠状动脉介入治疗后白细胞-血小板聚集、血小板表面P-选择素及血小板表面糖蛋白IIIa：达肝素或普通肝素联合阿昔单抗的影响
Am Heart J. 2001 Nov;142(5):790-8. doi: 10.1067/mhj.2001.119128.
7
ACP Journal Club. Review: enoxaparin during PCI is better than unfractionated heparin for reducing mortality in coronary heart disease.《美国内科医师学会杂志俱乐部》述评：经皮冠状动脉介入治疗期间使用依诺肝素在降低冠心病死亡率方面优于普通肝素。
Ann Intern Med. 2012 May 15;156(10):JC5-2. doi: 10.7326/0003-4819-156-10-201205150-02002.
8
Cost-effectiveness of dalteparin versus unfractionated heparin as venous thromboembolism prophylaxis in malignant gynecologic surgery.达肝素与普通肝素在妇科恶性肿瘤手术中预防静脉血栓栓塞的成本效益分析
Am J Ther. 2008 Nov-Dec;15(6):512-5. doi: 10.1097/MJT.0b013e3181727aa0.
9
Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.住院患者接受低分子量肝素治疗时血小板计数监测建议的依从性及可能的肝素诱导的血小板减少症的管理。
Ann Pharmacother. 2009 Sep;43(9):1405-12. doi: 10.1345/aph.1L646. Epub 2009 Aug 18.
10
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.达肝素对合并肾功能不全的重症内科及外科患者的血栓预防作用
J Crit Care. 2005 Dec;20(4):357-63. doi: 10.1016/j.jcrc.2005.09.009.

引用本文的文献

1
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.低分子量肝素用于预防下肢制动患者的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2017 Aug 6;8(8):CD006681. doi: 10.1002/14651858.CD006681.pub4.